APOLLOE4 Phase 3 study of oral ALZ-801/valiltramiprosate in APOE ε4/ε4 homozygotes with early Alzheimer's disease: Trial design and baseline characteristics.
Susan AbushakraAnton P PorsteinssonMarwan SabbaghDavid WatsonAidan PowerEarvin LiangEmer MacSweeneyMerce BoadaSusan FlintRosalind McLaineJ Patrick KesslakJohn A HeyMartin TolarPublished in: Alzheimer's & dementia (New York, N. Y.) (2024)
ε4/ε4 AD subjects.